Transfusion medicine
-
Transfusion medicine · Dec 1998
Meta AnalysisErythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Our aim was to perform a systematic review to determine the efficacy and side-effects of erythropoietin, given with or without autologous predonation, to patients undergoing orthopaedic or cardiac surgery. A number of studies have been done to determine whether erythropoietin minimizes exposure to perioperative allogeneic red cell transfusion. A systematic review of all randomized trials will provide the best estimate of the efficacy and side-effects of erythropoietin therapy. ⋯ Although there was no convincing evidence that erythropoietin used alone increased the frequency of thrombotic complications, some studies found an excess of events in erythropoietin-treated patients, and the number of patients studied was relatively small. Erythropoietin, when given alone or to augment autologous donation, decreased exposure to perioperative allogeneic transfusion in orthopaedic and cardiac surgery. Further studies are required to definitively establish the safety of erythropoietin alone, to determine the optimal dose of perioperative erythropoietin, and to compare its efficacy and cost-effectiveness with other methods of minimizing perioperative transfusion.
-
Transfusion medicine · Sep 1998
Changes in red-cell transfusion practice in a tertiary care hospital during the 1990s--a 7-year study.
Use of red cells for transfusion in a tertiary care hospital has been studied over a 7-year period from 1990-1991 to 1996-1997. In this time, red-cell use has declined by 18% while new patients or admissions to programmes in oncology, trauma or cardiac bypass surgery have increased by 57%, 66% and 73%, respectively. This reduction in red-cell transfusion has been achieved by a combination of less patients (proportionately) receiving red cells and less red cells being transfused to individual recipients. ⋯ Autologous presurgical blood deposit met about 45% of the blood requirement for those four procedures. A similar decreasing trend in units per patient and proportion of patients transfused red cells was seen for 'first-time' coronary artery bypass surgery. The question arises as to how far this trend may go before adverse effects of undertransfusion become apparent.
-
Transfusion medicine · Jun 1996
From maximum surgical blood ordering schedule to unlimited computer crossmatching: evolution of blood transfusion for surgical patients at a tertiary hospital in Hong Kong.
The maximum surgical blood ordering schedule (MSBOS) was developed to permit efficient use of blood stocks and reduce blood wastage due to outdating. Success of the MSBOS required full cooperation between surgeons, anaesthetists, blood bankers and house officers. ⋯ We developed a computer crossmatch system that could overcome the shortcomings of the MSBOS. The advantages of this system are reported.